...
首页> 外文期刊>Hospital pharmacy. >Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval Supplemental Applications Filed by Manufacturer Significant Labeling Changes or 'Dear Health Professional Letters Related to Safety
【24h】

Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval Supplemental Applications Filed by Manufacturer Significant Labeling Changes or 'Dear Health Professional Letters Related to Safety

机译:当前与FDA有关的药物信息由FDA批准的新药,由FDA代理商批准的新剂型和适应症,待FDA批准的制造商提出的补充申请重大的标签变更或“与安全有关的亲爱的健康专业人士”

获取原文
获取原文并翻译 | 示例
           

摘要

This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let me know at bakerdan@wsu.edu.
机译:该月度功能将帮助读者了解新药,新适应症,剂型以及与安全性有关的标签或用途变化。已努力确保此信息的准确性;但是,如果有任何疑问,请通过bakerdan@wsu.edu与我联系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号